Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Tel Aviv University and Harvard Medical School researchers developed a non-invasive technique that harnesses pulsed electric fields to generate growth of new skin tissue. The novel non-invasive tissue stimulation technique use microsecond-pulsed, high-voltage, non-thermal electric fields to produce scar-free skin rejuvenation. The report were published in the journal Scientific Reports.

  • A new study revealed, Liraglutide, an injectable diabetes drug that US regulators approved last year for weight loss, has helped obese people lose an average of 18 pounds (eight kilograms). The findings are published in the New England Journal of Medicine.

  • Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, launch generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States which are used to lower the risk of stroke in people who have had a mini-stroke (transient ischemic attack or TIA) or stroke due to a blood clot.

  • A single-celled marine plankton evolved a miniature version of a multi-cellular eye, possibly to help see its prey better, according to University of British Columbia (UBC) research published today in Nature.

    [adsense:336x280:8701650588]

  • Pinaverium bromide (pinaverium), an antispasmodic, is used widely in many countries around the world, including European countries, Canada and Mexico.  However, original clinical studies on pinaverium are scarce and there has been no convincing evidence for its effectiveness and safety. As such, the U.S. Food and Drug Administration (FDA) has not approved this treatment for use in the U.S. IBS is the most common chronic (life-long in some patients) and highly recurrent gastrointestinal disorder, with an estimated worldwide prevalence of 10 to 15%.

  • A method developed by a team of Israeli scientists to decode an individual's unique sense of smell which they call an "olfactory fingerprint" has been found, claims a new research. The paper was published in the journal Proceedings of the National Academy of Sciences (PNAS). This "olfactory fingerprinting", in addition to help identify individuals, can detect diseases such as Parkinson's and Alzheimer's early.

Subscribe to Pharma News